haylaavo

ANKURDRUGS

ANKURDRUGS · NSE · inactive
3.65
-0.15 (-3.95%)
as of 10 Sept 2013 close
Open
3.75
High
3.75
Low
3.65
Prev close
3.80
52w high
20.25
04 Oct 2012
52w low
3.65
04 Sept 2013
VWAP
3.65
Delivery %
—
n/a
Volume 10,260 · turnover ₹37,499 · NSE bhavcopy (official close) · history since 22 May 2007
Series
EQ
F&O
No
Status
Inactive since 11 Sept 2013

Source: NSE equity master · as of 10 Sept 2013

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 10:43 IST
AllM&AAGM / meetingAnalyst meetBoard meetingBusiness updateManagementComplianceCorporate actionCredit ratingDividendExchange queryGeneral updateInsider / SASTLegalOrder winResults
  • 14 Feb 2013 16:54
    Results

    Ankur Drugs And Pharma Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2012.

    PDF · -
  • 10 Nov 2012 18:28
    Results

    Ankur Drugs And Pharma Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2012.

    PDF · -
  • 14 Aug 2012 21:36
    Results

    Ankur Drugs And Pharma Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2012.

    PDF · -
  • 14 May 2012 21:19
    Results

    Ankur Drugs And Pharma Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2012.

    PDF · -
  • 02 Feb 2012 10:33
    Results

    Ankur Drugs And Pharma Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2011.

    PDF · -
  • 15 Nov 2011 18:09
    Results

    Ankur Drugs And Pharma Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2011.

    PDF · -
  • 16 May 2011 12:20
    Results

    Ankur Drugs And Pharma Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2011.

    PDF · -
  • 15 Feb 2011 12:11
    Results

    Ankur Drugs And Pharma Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2010.

    PDF · -
  • 15 Nov 2010 11:11
    Results

    Ankur Drugs And Pharma Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2010.

    PDF · -
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries